George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAminex Regulatory News (AEX)

Share Price Information for Aminex (AEX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.15
Bid: 1.10
Ask: 1.20
Change: -0.05 (-4.17%)
Spread: 0.10 (9.091%)
Open: 1.20
High: 1.20
Low: 1.15
Prev. Close: 1.20
AEX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Rump Placing

4 Aug 2016 07:00

RNS Number : 1977G
Aminex PLC
04 August 2016
 

NOT FOR FORWARDING, RELEASE, PUBLICATION OR DISTRIBUTION IN PART OR IN WHOLE DIRECTLY OR INDIRECTLY IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, NEW ZEALAND, SOUTH AFRICA OR SWITZERLAND OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION

 

4 August 2016

Aminex PLC

("Aminex" or "the Company")

 

Results of Rump Placing

 

Further to the announcement made on 1 August 2016 by Aminex regarding the results of the Open Offer, the Company confirms that Davy and Shore Capital have procured subscribers for the remaining 99,445,386 New Ordinary Shares not validly taken up in the Open Offer at the issue price of 1.3 pence per New Ordinary Share. Consequently the Company is pleased to announce that the Capital Raise of approximately Stg£19.5m has been fully subscribed.

 

Application has been made to the Irish Stock Exchange and to the UK Listing Authority for 197,620,548 Open Offer Shares to be admitted to the Official List of the Irish Stock Exchange and the Official List maintained by the UK Listing Authority, and application has been made to the Irish Stock Exchange and the London Stock Exchange for admission of the Open Offer Shares to trading on their respective main market for listed securities. It is expected that admission will become effective and that dealings in the Open Offers Shares will commence at 8.00 a.m. on 8 August 2016.

 

Updated Timetable of Events

 

Set out below is an expected timetable of the remaining principal events in relation to the completion of the Capital Raise.

 

Issue of Open Offer Shares

8 August 2016

Admission to trading and commencement of dealings in Open Offer Shares on the Irish and London Stock Exchanges

8.00 a.m. on 8 August 2016

Crediting of Open Offer Shares to CREST accounts

8.00 a.m. on 8 August 2016

Dispatch of definitive share certificates for the Open Offer Shares in certificated form by no later than

22 August 2016

 

Notes:

(1) The times and dates set out in the expected timetable of principal events above and mentioned throughout this announcement may be adjusted by the Company, in which event details of the new times and dates will be notified to the Irish Stock Exchange, the UK Listing Authority, the London Stock Exchange, and, where appropriate, Qualifying Shareholders by means of an announcement through a Regulatory Information Service.

(2) References to times in the timetable are to Dublin times unless otherwise stated.

 

This announcement should be read in conjunction with the full text of the prospectus relating to the Capital Raise published by the Company on 11 July 2016 ("the Prospectus"). All capitalised/defined terms in this announcement have the same meaning as those contained in the Prospectus.

 

For further information:

 

Aminex

Jay Bhattacherjee, Chief Executive Officer

Tel: +44 (0) 20 7291 3100

Davy

Brian Garrahy / Paul Burke

Tel: +353 (0) 1 679 6363

Shore Capital

Jerry Keen / Stephane Auton

Tel: + 44 (0) 20 7408 4090

Camarco

Billy Clegg / Gordon Poole

Tel: +44 (0) 20 3757 4980

 

This announcement has been issued by and is the sole responsibility of the Company.

 

J&E Davy (''Davy'') (each of which is regulated in Ireland by the Central Bank of Ireland) and Shore Capital Stockbrokers Limited and Shore Capital and Corporate Limited (together "Shore Capital", which is regulated in the UK by the Financial Services Authority) are acting exclusively for Aminex in connection with the matters described herein and for no one else and will not be responsible to any other person for providing the protection afforded to customers of Davy or Shore Capital respectively nor for providing advice in connection with this announcement. None of Davy, Shore Capital or any of their respective affiliates, their respective directors, officers, employees, agents, advisors have authorised the contents of, or any part of, this document.

 

No undertaking, representation, warranty or any other assurance, express or implied, is made or given by or on behalf of Davy or Shore Capital or any of their respective affiliates, their respective directors, officers, employees, agents, advisors or any other person, as to the accuracy, completeness, correctness or fairness of the information or opinions contained in this announcement or for any other statement made or purported to be made by any of them, or on behalf of them, in connection with the Company, the Cornerstone Placing, the Placing, the Open Offer or Admission and no such person shall have any responsibility or liability for any such information or opinions or for any errors or omissions. Accordingly, to the extent permitted by law, no liability whatsoever (including whether arising in tort, contract or otherwise) is accepted by Shore Capital or Davy or any of such persons' directors, officers, employees, agents, advisors or affiliates or any other person for any loss howsoever arising, directly or indirectly, from any use of this document or such information or opinions contained herein or otherwise arising in connection herewith.

 

The distribution of this announcement may be restricted by law and the persons into whose possession any document or other information referred to herein comes should inform themselves about and observe any such restriction. No action has been taken that would permit the possession or distribution of this announcement in any jurisdiction where action for that purpose is required.

 

Certain figures contained in this document, including financial information, have been subject to rounding adjustments. Accordingly, in certain instances, the sum or percentage change of the numbers contained in this document may not conform exactly with the total figure given.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ROIAKNDDFBKDAFK
Date   Source Headline
29th Feb 20247:00 amRNSRuvuma Seismic Update
10th Jan 20242:49 pmRNSRuvuma Gas Sales Agreement signed
31st Oct 20235:00 pmRNSKiliwani Operations Update
29th Sep 20237:00 amRNS2023 Half-Yearly Financial Report
1st Sep 20237:00 amRNSDirectorate Change
13th Jul 20234:26 pmRNSResult of AGM
12th Jul 20237:00 amRNSRuvuma Operations Update
20th Jun 20237:00 amRNSNotice of AGM
2nd Jun 20233:13 pmRNSDirector/PDMR Shareholding
26th May 20237:00 amRNSPublication of New Research
28th Apr 20236:13 pmRNSFinal Results and Annual Report 2022
2nd Mar 20237:00 amRNSStrategy/Company/Ops Update
6th Feb 202311:05 amRNSSecond Price Monitoring Extn
6th Feb 202311:00 amRNSPrice Monitoring Extension
6th Feb 20239:05 amRNSSecond Price Monitoring Extn
6th Feb 20239:00 amRNSPrice Monitoring Extension
28th Nov 202211:05 amRNSSecond Price Monitoring Extn
28th Nov 202211:00 amRNSPrice Monitoring Extension
28th Nov 20227:00 amRNSRuvuma Commercial Update
1st Nov 202211:05 amRNSSecond Price Monitoring Extn
1st Nov 202211:00 amRNSPrice Monitoring Extension
1st Nov 20229:05 amRNSSecond Price Monitoring Extn
1st Nov 20229:00 amRNSPrice Monitoring Extension
1st Nov 20227:23 amRNSRuvuma Operations Update
6th Oct 20224:41 pmRNSSecond Price Monitoring Extn
6th Oct 20224:35 pmRNSPrice Monitoring Extension
30th Sep 20227:00 amRNS2022 Half-Yearly Financial Report
1st Sep 202210:59 amRNSRuvuma PSA
1st Sep 20227:00 amRNSRuvuma Seismic and Commercial Update
18th Aug 20222:05 pmRNSSecond Price Monitoring Extn
18th Aug 20222:00 pmRNSPrice Monitoring Extension
18th Aug 202211:05 amRNSSecond Price Monitoring Extn
18th Aug 202211:00 amRNSPrice Monitoring Extension
8th Aug 20227:00 amRNSKiliwani Operations Update
1st Aug 20227:00 amRNSStrategy/Company/Ops Update
13th Jul 20224:23 pmRNSRuvuma PSA
6th Jun 20222:06 pmRNSSecond Price Monitoring Extn
6th Jun 20222:00 pmRNSPrice Monitoring Extension
1st Jun 20223:41 pmRNSTotal Voting Rights
26th May 20224:04 pmRNSResult of AGM
4th May 20227:00 amRNSNotice of AGM
11th Apr 20227:00 amRNSFinal Results and Annual Report 2021
8th Apr 20227:00 amRNSTanzania Operations Update
1st Apr 20224:41 pmRNSSecond Price Monitoring Extn
1st Apr 20224:36 pmRNSPrice Monitoring Extension
1st Apr 20222:05 pmRNSSecond Price Monitoring Extn
1st Apr 20222:00 pmRNSPrice Monitoring Extension
1st Apr 202211:09 amRNSSuccessful Placing to Fund Aminex to First Gas
28th Mar 20222:05 pmRNSSecond Price Monitoring Extn
28th Mar 20222:00 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.